Heptares Therapeutics
0 followers
Heptares Therapeutics is a drug discovery company focused on novel small-molecule drugs targeting G-protein-coupled receptors (GPCRs), the largest family of druggable targets.The Company has developed a unique, transformational and proprietary technology for making purified, stabilised and functiona... Read more
Org chart
Chris Cargill
Chief Executive Officer
Chris Cargill
Collapse
Candelle Chong
Executive Vice President, Chief of Staff
Chris de Graaf
Senior Director, Head of Computational Chemistry
Gareth Waldron
Senior Director, Head Preclinical Development
Gerry McAnally
Head of IP
Helen Carberry
Head of Human Resources
Hironoshin Nomura
Chief Financial Officer
Jayesh Patel
Director, Protein Engineering
Kieran Johnson
Chief Accounting Officer
Mathieu Rappas
Director and Head of Biochemistry
Matt Barnes
President of Heptares Therapeutics Ltd. and Head of UK R&D
Matthew Foxwell
Director Of Information Technology
Nigel Swain
Vice President, Head Of Discovery
Shinichiro N.
Vice President, IR & Corporate Strategy Department
Takuya Saiki
Vice President Clinical Development Dept.
Mariko Nakafuji
General Counsel
